Versant Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.32K | Sell |
562
-28
| -5% | -$414 | ﹤0.01% | 1970 |
|
|
2025
Q1 | $10.6K | Hold |
590
| – | – | ﹤0.01% | 1703 |
|
|
2024
Q4 | $10.3K | Buy |
+590
| New | +$10.3K | ﹤0.01% | 1378 |
|
|
2024
Q2 | – | Sell |
-61
| Closed | -$470 | – | 2011 |
|
|
2024
Q1 | $470 | Buy |
+61
| New | +$470 | ﹤0.01% | 1709 |
|
|
2023
Q3 | – | Sell |
-9
| Closed | -$138 | – | 2058 |
|
|
2023
Q2 | $138 | Buy |
+9
| New | +$138 | ﹤0.01% | 2019 |
|